Bayer outlines a $7.25 billion nationwide framework to resolve thousands of Roundup claims, boosts reserves and signals near-term financial pressure.

Company says settlement would address bulk of outstanding cases; the Supreme Court has agreed to hear Bayer’s appeal to neutralize cancer claims.

By Diana Novak Jones March 4 (Reuters) - A state court judge in Missouri gave an initial green light on Wednesday to a proposed $7.25 billion settlement to resolve thousands of lawsuits claiming Bayer ...

Announced today, Bayer’s subsidiary Monsanto has reached a class settlement deal—pending court approval—to reach the company’s goal of containing glyphosate litigation. The deal includes $7.25 billion ...

Bayer said on Tuesday that its Monsanto chemical subsidiary has proposed a $7.25 billion settlement to resolve lawsuits by customers alleging that its Roundup weedkiller product caused non-Hodgkin ...

Bayer’s $7.25B Roundup settlement gains initial approval in Missouri, potentially resolving thousands of cancer lawsuits tied to glyphosate exposure.

By Diana Novak Jones Feb 17 (Reuters) - Bayer said on Tuesday its Monsanto unit had reached an agreement worth as much as $7.25 billion to resolve tens of thousands of current and future lawsuits ...

The Missouri court handling the proposed class settlement gave preliminary approval, though some plaintiffs petitioned to intervene ...

Bayer proposed a $7.25B nationwide settlement over Roundup cancer claims. The litigation stems partly from its 2018 acquisition of Monsanto. The U.S. Supreme Court will hear an appeal that could limit ...

Bayer said on Tuesday its Monsanto unit had reached an agreement worth as much as $7.25 billion to resolve tens of thousands of current and future lawsuits claiming that its Roundup weedkiller caused ...